Inactive Instrument

Transcripts Interpace Biosciences, Inc. Other OTC

Equities

IDXG

US46062X3035

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : Interpace Biosciences, Inc. - Shareholder/Analyst Call	08/11/21
Interpace Biosciences, Inc. Provides Revenue Guidance for the Full Year 2021	10/08/21	CI
Interpace Biosciences, Inc. Provides Revenue Guidance Second Quarter of Fiscal 2021	11/05/21	CI
Interpace Biosciences, Inc. Provides Full Year Revenue Guidance for 2021	31/03/21	CI
Transcript : Interpace Biosciences, Inc., Q3 2020 Earnings Call, Jan 21, 2021	21/01/21
Interpace Biosciences, Inc. Provides Earnings Guidance for the Fourth Quarter of 2020	20/01/21	CI
Transcript : Interpace Biosciences, Inc., Q2 2020 Earnings Call, Oct 21, 2020	21/10/20
Interpace Biosciences, Inc. Provides Revenue Guidance for the Third Quarter of 2020	20/10/20	CI
Transcript : Interpace Biosciences, Inc. - Shareholder/Analyst Call	09/07/20
Transcript : Interpace Biosciences, Inc., Q1 2020 Earnings Call, Jun 25, 2020	25/06/20
Interpace Biosciences, Inc. Provides Revenue Guidance for Second Quarter of 2020	25/06/20	CI
Interpace Biosciences, Inc. Provides Earnings Guidance for the First Quarter of 2020; Withdraws Its Previously Announced Annual Revenue Guidance for 2020	22/04/20	CI
Transcript : Interpace Biosciences, Inc., Q4 2019 Earnings Call, Apr 22, 2020	22/04/20
Transcript : Interpace Diagnostics Group, Inc., Q3 2019 Earnings Call, Nov 13, 2019	13/11/19
Interpace Biosciences, Inc. Announces Adjusting Revenue Guidance for the Year 2019 and Provides Revenue Guidance for the Full Year 2020	12/11/19	CI
Transcript : Interpace Diagnostics Group, Inc., Q2 2019 Earnings Call, Aug 13, 2019	13/08/19
Transcript : Interpace Diagnostics Group, Inc., Q1 2019 Earnings Call, May 13, 2019	13/05/19
Interpace Diagnostics Group, Inc. Provides Revenue Guidance for the Year 2019	13/05/19	CI
Transcript : Interpace Diagnostics Group, Inc., Q4 2018 Earnings Call, Mar 19, 2019	19/03/19
Interpace Diagnostics Group, Inc. Provides Revenue Guidance for the Year Ended December 31, 2018	28/02/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Interpace Biosciences, Inc. Other OTC

Equities

IDXG

US46062X3035

Transcripts

Filters